Heart Failure after Ischemic Stroke or TIA in Insulin-Resistant Patients without Diabetes Treated with Pioglitazone

BACKGROUND: The Insulin Resistance Intervention after Stroke (IRIS) trial demonstrated that pioglitazone reduced risk for both cardiovascular events and diabetes in insulin resistant patients. However, concern remains that pioglitazone may increase risk for heart failure (HF) in susceptible individu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation
Hauptverfasser: Young, Lawrence H., Viscoli, Catherine M., Schwartz, Gregory G., Inzucchi, Silvio E., Curtis, Jeptha P., Gorman, Mark J., Furie, Karen L., Conwit, Robin, Spatz, Erica, Lovejoy, Anne, Abbott, J. Dawn, Jacoby, Daniel L., Kolansky, Daniel M., Ling, Frederick S., Pfau, Steven E., Kernan, Walter N.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6202153/
https://ncbi.nlm.nih.gov/pubmed/29934374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.118.034763
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge